Back to top
more

Aytu BioPharma, Inc. (AYTU)

(Delayed Data from NSDQ)

$2.31 USD

2.31
53,613

+0.21 (9.74%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $2.24 -0.07 (-3.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks News

Zacks Equity Research

Aytu Bioscience, Inc. (AYTU) Stock Sinks As Market Gains: What You Should Know

Aytu Bioscience, Inc. (AYTU) closed at $1.52 in the latest trading session, marking a -1.3% move from the prior day.

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for April 3rd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 3rd

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for April 2nd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 2nd

Zacks Equity Research

Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?

Is (AYTU) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Aytu BioScience (AYTU) in Focus: Stock Moves 6.4% Higher

Aytu BioScience (AYTU) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Zacks Equity Research

Aytu BioScience to Issue Coronavirus Rapid Test in North America

Aytu BioScience (AYTU) expands the right to distribute and commercialize the COVID-19 IgG/IgM rapid test across the United States, Canada and Mexico. Stock jumps.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

Sanghamitra Saha headshot

Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

Zacks Equity Research

Coronavirus Test Kit Demand to Drive These 3 Stocks

Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.

Zacks Equity Research

Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?

Is (AYTU) Outperforming Other Medical Stocks This Year?